Particularly attractive are innovators like biopharma developer InMed Pharmaceuticals, Inc. (CSE:IN) (OTC:IMLFF) (InMed Profile), which has a compelling biosynthesis technology that will allow the company to manufacture bio-identical cannabinoids of every naturally occurring ones in-house, without … Read More
The post Cannabis Stock Bull Market Primed for Even More Growth as Major Markets Legalize appeared first on Dagga Magazine.